Pia Stillemark-Billton
Impact in
- Biochemistry top 2%
- Lipid metabolism and biosynthesis
-
- Lipid metabolism and disorders
Papers in
-
- Lipid metabolism and disorders 6
- Chemotherapy-induced cardiotoxicity and mitigation 1
-
- Proteoglycans and glycosaminoglycans research 3
- Co-authors
- Sven‐Olof Olofsson (7 shared papers)Lennart Asp (4 shared papers)Jan Borén (9 shared papers)Sabina Rustaeus (5 shared papers)David Gordon (1 shared paper)Pontus Boström (2 shared papers)Björn Magnusson (2 shared papers)Thomas P. Larsson (3 shared papers)
- Journals
- Atherosclerosis (3 papers)Journal of Lipid Research (2 papers)Journal of Biological Chemistry (2 papers)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)Scandinavian Cardiovascular Journal (1 paper)
- Partner nations
- SwedenUnited StatesAustralia
In The Last Decade
Pia Stillemark-Billton
16 papers receiving 844 citations
Peers
Comparison fields: 5 of 54
- Biochemistry 160
- Cardiology and Cardiovascular Medicine 247
- Surgery 264
- Cell Biology 84
- Hepatology 29
Countries citing papers authored by Pia Stillemark-Billton
This map shows the geographic impact of Pia Stillemark-Billton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pia Stillemark-Billton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pia Stillemark-Billton more than expected).
Fields of papers citing papers by Pia Stillemark-Billton
This network shows the impact of papers produced by Pia Stillemark-Billton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pia Stillemark-Billton. The network helps show where Pia Stillemark-Billton may publish in the future.
Co-authors
The 25 scholars most cited alongside Pia Stillemark-Billton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 155 | |
| 2 | 2006 | 136 | |
| 3 | 2000 | 115 | |
| 4 | 1998 | 114 | |
| 5 | 1999 | 67 | |
| 6 | 2000 | 65 | |
| 7 | 2004 | 49 | |
| 8 | 2009 | 45 | |
| 9 | 2005 | 32 | |
| 10 | 2010 | 30 | |
| 11 | 2009 | 29 | |
| 12 | 2019 | 18 | |
| 13 | 2009 | 7 | |
| 14 | 2012 | 3 | |
| 15 | 1999 | 1 | |
| 16 | 1999 | 1 |
About Pia Stillemark-Billton
Pia Stillemark-Billton is a scholar working on Cardiology and Cardiovascular Medicine, Cell Biology, Surgery, Biochemistry and Pathology and Forensic Medicine, having authored 16 papers that have together received 867 indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (7 papers), Lipid metabolism and disorders (6 papers), Proteoglycans and glycosaminoglycans research (3 papers), Lipid metabolism and biosynthesis (2 papers), Tea Polyphenols and Effects (1 paper), Cardiac Ischemia and Reperfusion (1 paper), Chemotherapy-induced cardiotoxicity and mitigation (1 paper) and RNA Interference and Gene Delivery (1 paper). The work is most often cited by research in Biochemistry (160 citations), Cardiology and Cardiovascular Medicine (247 citations), Surgery (264 citations), Cell Biology (84 citations) and Hepatology (29 citations). Pia Stillemark-Billton has collaborated with scholars based in Sweden, United States and Australia. Frequent co-authors include Sven‐Olof Olofsson, Lennart Asp, Jan Borén, Sabina Rustaeus, David Gordon, Pontus Boström, Björn Magnusson, Thomas P. Larsson, Germán Camejo and Annika Asplund. Their work appears in journals such as Atherosclerosis, Journal of Lipid Research, Journal of Biological Chemistry, Arteriosclerosis Thrombosis and Vascular Biology and Scandinavian Cardiovascular Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.